Breaking News

ICON Appoints Metabolic Research Head

By Kristin Brooks | January 20, 2014

Dr. Elahi brings 30 years of research experience

Dr. Dariush Elahi has been appointed director of Metabolic Research at ICON plc. Dr. Elahi will lead ICON’s early phase glucose clamping programs globally, providing scientific consultation to sponsors developing therapeutics to treat endocrine/metabolic disease. He’ll be based in the company’s Clinical Pharmacology Unit in San Antonio, TX.
Dr. Elahi is a clinical physiologist with more than 30 years of research experience focused on translational investigations of the regulation of glucose homeostasis. His expertise includes kinetics analyses of fuel substrates using both stable and radioactive tracers and the employment of these techniques during clamp studies. Dr. Elahi has authored 147 scientific publications and is nationally and internationally recognized for his work on the role of insulin. He has served as a professor at The Johns Hopkins University School of Medicine, Harvard Medical School, and the University of Pennsylvania’s Perelman School of Medicine. He also served as Research Physiologist and Senior Staff Fellow at the National Institutes of Health (NIH) and National Institutes on Aging.

blog comments powered by Disqus
  • Cryogenic Cold Chain Risk Mitigation

    Cryogenic Cold Chain Risk Mitigation

    Kristin Brooks, Contract Pharma||November 13, 2015
    Mark Sawicki of Cryoport explains the requirements, challenges, and regulatory aspects around cryogenic logistics

  • A Biologic Innovator

    A Biologic Innovator's Pursuit to Uphold Patents

    Kristin Brooks, Contract Pharma||October 12, 2015
    Amgen v. Sandoz biosimilars litigation could impact the industry for years to come

  • 2015 Contracting & Outsourcing Wrap-up

    2015 Contracting & Outsourcing Wrap-up

    Kristin Brooks, Contract Pharma||September 30, 2015
    A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies

  • Bringing Transparency and Collaboration to CRO Oversight

    Bringing Transparency and Collaboration to CRO Oversight

    Craig Morgan , goBalto Inc. ||November 17, 2015
    Relationships between sponsors and CROs are getting stronger